Mural Oncology Reports Inducement Grants Under Nasdaq
DUBLIN, Ireland, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company leveraging its core competencies in...
Vivos Therapeutics Announces Exercise of Warrants for
LITTLETON, Colo., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and...
Ultra Lithium Granted Voluntary Management Cease Trade
VANCOUVER, British Columbia, March 04, 2024 (GLOBE NEWSWIRE) -- Ultra Lithium Inc. (TSXV: ULT OTCQB: ULTXF Frankfurt: QFB) (“Ultra Lithium” or the...
CoreCivic Announces Closing of Offering of $500 Million of
BRENTWOOD, Tenn., March 12, 2024 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) (“CoreCivic”) announced today that it has completed the previously announced...
Movella Files Form 25 to Voluntarily Delist its Securities
HENDERSON, Nev., April 01, 2024 (GLOBE NEWSWIRE) -- Movella Holdings Inc. (NASDAQ: MVLA) (“Movella” or the “Company”), a leading full-stack provider of...
Existing-Home Sales Descended 4.3% in March
Washington, D.C., April 18, 2024 (GLOBE NEWSWIRE) -- Key Highlights Existing-home sales retreated 4.3%...
H World Group Limited Announces Completion of the Put Right
SHANGHAI, China, April 30, 2024 (GLOBE NEWSWIRE) -- H World Group Limited (Nasdaq: HTHT and HKEx: 1179, the “Company” or “H World”),...
$4.3 million Placement
Not for release to US wire services or distribution in the United States TORONTO, Nov. 20, 2023 ...
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq
BOSTON, Dec. 04, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare...
Fate Therapeutics Reports New Employee Inducement Grants
SAN DIEGO, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class...
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule
CAMBRIDGE, Mass., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that,...
Tuttle Capital Management Launches 2x Inverse Regional Bank
GREENWICH, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE) -- via IBN -- The 2x Inverse Regional Bank ETF, (NASDAQ: SKRE), will start trading...
